US appeals court again invalidates Teva MS drug patent

By REUTERS
June 18, 2015 19:13

NEW YORK - A US appeals court on Thursday once again invalidated a patent held by Teva Pharmaceutical Industries Ltd on its top-selling multiple sclerosis drug Copaxone, clearing the way for the launch of a cheaper, generic version.

The decision is the second time the US Court of Appeals for the Federal Circuit has reviewed the Teva patent and comes after the US Supreme Court in January asked it to reconsider a previous decision to cancel the patent.


Related Content

Breaking news
April 20, 2018
Iran to Israel: Fingers are on the trigger, missiles are ready to launch

By JPOST.COM STAFF

Israel Weather
  • 16 - 27
    Beer Sheva
    18 - 23
    Tel Aviv - Yafo
  • 16 - 23
    Jerusalem
    16 - 22
    Haifa
  • 23 - 36
    Elat
    17 - 28
    Tiberias